Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
UNCY
Stock Latest News
The Fly
Unicycive Therapeutics management to meet with Piper Sandler
2d ago
UNCY
Premium
The Fly
Unicycive Therapeutics initiated with a Buy at WestPark Capital
3d ago
UNCY
Premium
Ratings
De-Risked Regulatory Path and Commercial Readiness Underpin Buy Rating on Unicycive and Lead Asset OLC
24d ago
UNCY
Premium
The Fly
Unicycive Therapeutics announces FDA acceptance of OLC NDA resubmission
24d ago
UNCY
Premium
Ratings
De-Risked NDA Resubmission and TDAPA Tailwinds Support Buy Rating on Unicycive and OLC Commercial Upside
2M ago
UNCY
Premium
The Fly
Unicycive Therapeutics resubmits NDA for oxylanthanum carbonate
2M ago
UNCY
Premium
Ratings
Unicycive Therapeutics: Buy Rating Backed by Promising OLC Progress and Strategic Market Positioning
3M ago
UNCY
Premium
Company Announcements
Unicycive Therapeutics Doubles Stock Sale Agreement
3M ago
8K
UNCY
Premium
Ratings
Positive Outlook for Unicycive Therapeutics Amidst Promising Developments and Financial Stability
3M ago
UNCY
Premium
The Fly
Unicycive Therapeutics reports Q3 EPS (46c), consensus (53c)
3M ago
UNCY
Premium
The Fly
Unicycive Therapeutics sees cash runway into 2027
3M ago
UNCY
Premium
The Fly
Ten new option listings on November 5th
4M ago
AIS
DRTS
Premium
Ratings
Optimistic Buy Rating for Unicycive Therapeutics Driven by Promising Clinical Progress and Financial Stability
4M ago
UNCY
Premium
The Fly
Unicycive Therapeutics to present new OLC data at ASN Kidney Week 2025
4M ago
UNCY
Premium
The Fly
Unicycive Therapeutics price target raised to $22 from $9 at H.C. Wainwright
4M ago
UNCY
Premium
Company Announcements
Unicycive Therapeutics Updates FDA Application for OLC
4M ago
8K
UNCY
Premium
The Fly
Unicycive provides update on meeting with FDA, resubmission of NDA for OLC
4M ago
UNCY
Premium
Market News
UNCY Lawsuit Alert! Class Action Lawsuit Against Unicycive Therapeutics
5M ago
UNCY
Premium
The Fly
Unicycive Therapeutics price target adjusted at Benchmark after reverse split
5M ago
UNCY
Premium
Class Action
Unicycive Faces Class Action Over FDA Misleading Claims
6M ago
UNCY
Premium
Company Announcements
Unicycive Faces Securities Lawsuit Over Drug Claims
6M ago
8K
UNCY
Premium
The Fly
Unicycive Therapeutics granted new U.S. patent for UNI-494 to treat CKD
6M ago
UNCY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
